Amedisys (AMED)
(Delayed Data from NSDQ)
$96.71 USD
-0.09 (-0.09%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $96.71 0.00 (0.00%) 7:54 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.71 USD
-0.09 (-0.09%)
Updated Nov 8, 2024 03:59 PM ET
After-Market: $96.71 0.00 (0.00%) 7:54 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Zacks News
Amedisys Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Amedisys has been struggling lately, but the selling pressure may be coming to an end soon.
Has the Trade Debacle Ended for US MedTech Space? 3 Picks
by Sreyoshi Mukherjee
As the trade war fears slowly dissipate, let's take a look at three profitable U.S. MedTech picks.
Here's Why You Should Add Amedisys (AMED) to Your Portfolio
by Zacks Equity Research
Amedisys (AMED) is developing and acquiring new business lines that will complement its existing home care and hospice business.
Amedisys (AMED) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Amedisys (AMED) closed at $114.79, marking a +0.88% move from the previous day.
Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
5 Great Healthcare Stocks to Buy for 2019
by Swarup Gupta
Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath
by Nalak Das
Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.
Ring in 2019 With These 7 Solid Growth Stocks in Your Kitty
by Madhura Bhattacharyya
Let's take a look at seven growth stocks that are poised to offer impressive returns in 2019.
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
by Zacks Equity Research
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
Ride on DuPont Analysis With 5 Top Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
4 Healthcare Stocks That Popped More Than 100% in 2018
by Sapna Bagaria
Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.
4 Medical Device Stocks That More Than Doubled in 2018
by Sweta Jaiswal
Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.
Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock
by Zacks Equity Research
Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock
5 Stocks With Recent Price Strength to Enhance Your Return
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
5 Stocks That Popped More Than 100% in 2018 Defying All Odds
by Sreyoshi Mukherjee
Five solid picks that defied the problems confronting the U.S. economy.
Has Amedisys (AMED) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
by Zacks Equity Research
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
Bull of the Day: Amedisys (AMED)
by Madeleine Johnson
After blowout earnings, can this top hospice provider push higher?
Bet on DuPont Analysis With 5 Top-Ranked Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Amedisys (AMED) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Amedisys, Inc. (AMED).
Here's Why You Should Add Amedisys (AMED) to Your Portfolio
by Zacks Equity Research
Amedisys (AMED) continues to see impressive performance by Personal Care business. The company's focus on improving clinical quality buoys optimism.